Articles by Disease (Diabetes Mellitus)

Thienopyridines in Percutaneous Coronary Interventions: Standard Procedures and High Risk Subsets

Journal: Current Pharmaceutical Design
Volume: 12
Page: 1281-1286
Author(s): Peter W. Radke, Rainer Hoffmann, Alma Zernecke, Axel Kaiser, Heribert Schunkert and Christian Weber

The Role of Antiplatelet Agents in the Management of Patients Receiving Intracardiac Closure Devices

Journal: Current Pharmaceutical Design
Volume: 12
Page: 1287-1291
Author(s): Andreas Franke and Harald P. Kuhl

Primary and Secondary Stroke Prevention with Antiplatelet Drugs

Journal: Current Pharmaceutical Design
Volume: 12
Page: 1293-1297
Author(s): Hans-Christoph Diener

Whole Embryo Culture: An Important Tool in Developmental Toxicology Today

Journal: Current Pharmaceutical Design
Volume: 12
Page: 1467-1488
Author(s): B. Flick and S. Klug

Atorvastatin and Diabetic Vascular Complications

Journal: Current Pharmaceutical Design
Volume: 12
Page: 1549-1554
Author(s): Sho-ichi Yamagishi, Takanori Matsui and Kazuo Nakamura

Inhibition of GSK3 Dependent Tau Phosphorylation by Metals

Journal: Current Alzheimer Research
Volume: 3
Page: 123-127
Author(s): Alberto Gomez-Ramos, Jorge Dominguez, Delia Zafra, Helena Corominola, Ramon Gomis, Joan J. Guinovart and Jesus Avila

Cholinesterase Inhibitors Slow Decline in Executive Functions, Rather than Memory, in Alzheimers Disease: A 1-Year Observational Study in the Sunnybrook Dementia Cohort

Journal: Current Alzheimer Research
Volume: 3
Page: 147-156
Author(s): Pearl Behl, Krista L. Lanctot, David L. Streiner, Isabelle Guimont and Sandra E. Black